Quick Takeaways
- Robert Disbrow filed SCHEDULE 13G/A for Eupraxia Pharmaceuticals Inc. Common Shares, with no par value (EPRX).
- Disclosed ownership: 7%.
- Date of event: 30 Sep 2025.
Robert Disbrow - 30 Sep 2025 SCHEDULE 13G/A Report for Eupraxia Pharmaceuticals Inc. Common Shares, with no par value (EPRX)
- Filing Manager
- Robert Disbrow
- Reporting Manager
- Robert Disbrow
- Symbol
- EPRX
- Shares outstanding
- 50,973,571 shares
- Disclosed Ownership
- 3,568,150 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:37:06 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Robert Disbrow disclosed 7% ownership in Eupraxia Pharmaceuticals Inc. Common Shares, with no par value (EPRX) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 16:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Robert Disbrow | 7% | 3,568,150 | 0 | 3,568,150 | /s/ Robert Disbrow | Robert Disbrow |